Reasons for nonadherence to the direct oral anticoagulant apixaban for atrial fibrillation.
作者信息
Tarn Derjung M, Shih Kevin J, Schwartz Janice B
机构信息
Department of Family Medicine, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, California, USA.
Division of Geriatrics, Department of Medicine and Division of Clinical Pharmacology, Departments of Medicine and Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California, USA.
出版信息
J Am Geriatr Soc. 2021 Dec;69(12):3683-3687. doi: 10.1111/jgs.17423. Epub 2021 Aug 27.
Abstract
摘要
相似文献
1
Reasons for nonadherence to the direct oral anticoagulant apixaban for atrial fibrillation.
J Am Geriatr Soc. 2021 Dec;69(12):3683-3687. doi: 10.1111/jgs.17423. Epub 2021 Aug 27.
2
After the AUGUSTUS Trial, Should Apixaban Be the Only Direct Oral Anticoagulant to Be Used in Triple Therapy in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention?
Cardiovasc Drugs Ther. 2019 Aug;33(4):499-500. doi: 10.1007/s10557-019-06886-w.
3
Might apixaban be the optimal oral anticoagulant for haemophiliacs with atrial fibrillation?
Haemophilia. 2015 Jul;21(4):e338-40. doi: 10.1111/hae.12709. Epub 2015 May 4.
4
Importance of balancing follow-up time and impact of oral-anticoagulant users' selection when evaluating medication adherence in atrial fibrillation patients treated with rivaroxaban and apixaban.
Curr Med Res Opin. 2017 Jun;33(6):1033-1043. doi: 10.1080/03007995.2017.1297932. Epub 2017 Apr 2.
5
Trends in use of warfarin and direct oral anticoagulants in atrial fibrillation in Norway, 2010 to 2015.
Eur J Clin Pharmacol. 2017 Nov;73(11):1417-1425. doi: 10.1007/s00228-017-2296-1. Epub 2017 Jul 22.
6
Is Apixaban (Eliquis) the "ideal" anticoagulant to replace warfarin for stroke prevention in atrial fibrillation?
S D Med. 2013 Jan;66(1):20-1.
7
Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Adv Ther. 2012 Jun;29(6):491-507. doi: 10.1007/s12325-012-0026-8. Epub 2012 Jun 7.
8
Apixaban versus warfarin in atrial fibrillation.
N Engl J Med. 2012 Jan 5;366(1):88-9; author reply 89-90. doi: 10.1056/NEJMc1112500.
9
Cost-effectiveness of apixaban versus other new oral anticoagulants for stroke prevention in atrial fibrillation.
Clin Ther. 2014 Feb 1;36(2):192-210.e20. doi: 10.1016/j.clinthera.2013.12.011. Epub 2014 Feb 6.
10
Assessment of Apixaban Prescribing Patterns for Nonvalvular Atrial Fibrillation in Hospitalized Patients.
Ann Pharmacother. 2018 Jan;52(1):54-59. doi: 10.1177/1060028017726795. Epub 2017 Aug 11.
引用本文的文献
1
Reasons for Nonadherence to the Direct Oral Anticoagulant Apixaban: A Cross-Sectional Survey of Atrial Fibrillation Patients.
JACC Adv. 2023 Jan 27;2(1):100175. doi: 10.1016/j.jacadv.2022.100175. eCollection 2023 Jan.
2
Current Gaps in the Provision of Safe and Effective Anticoagulation in Atrial Fibrillation and the Potential for Factor XI-Directed Therapeutics.
Crit Pathw Cardiol. 2024 Jun 1;23(2):47-57. doi: 10.1097/HPC.0000000000000351. Epub 2024 Feb 21.
3
Eliminating Health Disparities in Atrial Fibrillation, Heart Failure, and Dyslipidemia: A Path Toward Achieving Pharmacoequity.
Curr Atheroscler Rep. 2023 Dec;25(12):1113-1127. doi: 10.1007/s11883-023-01180-5. Epub 2023 Dec 18.
4
Comparison of the DOAC Dipstick Test on Urine Samples With Chromogenic Substrate Methods on Plasma Samples in Outpatients Treated With Direct Oral Anticoagulants.
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231179684. doi: 10.1177/10760296231179684.
5
Ischemic Stroke and Systemic Embolism Among One-and-Done Direct Oral Anticoagulant Users with Non-valvular Atrial Fibrillation.
Adv Ther. 2023 May;40(5):2339-2354. doi: 10.1007/s12325-023-02483-4. Epub 2023 Mar 22.
6
Patient adherence and comprehension of take-home anticoagulant regimens prescribed at the emergency department: preliminary findings from a randomized controlled trial and implications for patient safety.
Intern Emerg Med. 2022 Apr;17(3):921-924. doi: 10.1007/s11739-021-02872-z. Epub 2021 Nov 2.
本文引用的文献
1
Veterans Perceptions of Satisfaction and Convenience with Anticoagulants for Atrial Fibrillation: Warfarin versus Direct Oral Anticoagulants.
Patient Prefer Adherence. 2020 Oct 13;14:1911-1922. doi: 10.2147/PPA.S279621. eCollection 2020.
2
Oral Anticoagulant Utilization in the United States and United Kingdom.
J Gen Intern Med. 2020 Aug;35(8):2505-2507. doi: 10.1007/s11606-020-05904-0. Epub 2020 Jun 8.
3
Adherence to oral anticoagulants among patients with atrial fibrillation: a systematic review and meta-analysis of observational studies.
BMJ Open. 2020 Apr 8;10(4):e034778. doi: 10.1136/bmjopen-2019-034778.
4
Real-World Adherence and Persistence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Circ Cardiovasc Qual Outcomes. 2020 Mar;13(3):e005969. doi: 10.1161/CIRCOUTCOMES.119.005969. Epub 2020 Mar 9.
5
Patients' preferences for new versus old anticoagulants: a mixed-method vignette-based study.
Eur J Cardiovasc Nurs. 2018 Jun;17(5):429-438. doi: 10.1177/1474515117739618. Epub 2017 Nov 1.
6
Screening for cognitive impairment: comparing the performance of four instruments in primary care.
J Am Geriatr Soc. 2012 Jun;60(6):1027-36. doi: 10.1111/j.1532-5415.2012.03967.x. Epub 2012 May 30.
Zotero 插件